Table 3 Clinical variables and outcomes of patients according to in-hospital survival status
Survivors (n = 11) | Non-survivors (n = 10) | p | |
|---|---|---|---|
Age, years | 55.4 ± 17.7 | 54.1 ± 15.1 | 0.863 |
Male sex | 8 (72.7%) | 7 (70.0%) | 0.890 |
Smoking | 3 (27.3%) | 3 (30.0%) | 0.890 |
BMI (kg/m2) | 25.8 ± 3.4 | 24.7 ± 3.9 | 0.500 |
Cardiac arrest | 2 (18.2%) | 9 (90.0%) | 0.001 |
CPR duration, minutes | 6.1 ± 14.5 | 36.3 ± 19.2 | |
Post-ECMO thrombolytic therapy | 6 (54.5%) | 2 (20.0%) | 0.104 |
Major complications | |||
Neurologic impairment | 0 (0.0%) | 10 (100.0%) | < 0.001 |
Acute kidney injury required dialysis | 0 (0.0%) | 7 (70.0%) | 0.001 |
Major bleeding | 1 (9.1%) | 0 (0.0%) | 0.329 |
ECMO-related complications | 1 (9.1%) | 1 (10.0%) | 0.943 |
ECMO duration, days | 5.0 ± 2.6 | 5.3 ± 5.8 | 0.454 |
MV duration, days | 10.3 ± 8.7 | 6.3 ± 6.6 | 0.125 |
ICU LOS, days | 15.6 ± 8.3 | 6.3 ± 6.6 | 0.012 |
Hospital LOS, days | 29.9 ± 16.0 | 6.3 ± 6.6 | < 0.001 |